NeoGenomics (NEO) Reports In-Line Q4 EPS, Offers Guidance

NeoGenomics (NASDAQ: NEO) reported Q4 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $106.9 million versus the consensus estimate of $104.24 million.

GUIDANCE:

NeoGenomics sees FY2020 revenue of $464-474 million, versus the consensus of $448.3 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Spirit Blockchain Capital reports AGM results and board changes
• General Aerospace (GE) Tops Q2 EPS by 16c, Beats on Revenue; Offers FY26 EPS Guidance